PapersPMID:39275290
Effects of Casein-Derived Peptide Met-Lys-Pro on Systolic and Diastolic Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.
- findings
- 3
- compound
- 1
- endpoints
- 3
- no difference found
- 1
- Study, every finding
- RCT · 3 months
- Dose studied, every finding
- one sachet once daily containing 100 ug Met-Lys-Pro, taken with a drink, 12 weeks
What moved
How to read these marks →“SBP (ls mean ± SE) was 123.0 ± 1.4 mmHg in the MKP group and 128.1 ± 1.4 mmHg in the placebo group at Week 12, which was significantly lower in the MKP group (ANCOVA; p < 0.05).”
- Interests
- Industry funded
- Population
- Healthy Japanese adults aged 20 to 74 with high-normal or elevated blood pressure (SBP 120-139 mmHg and/or DBP 80-89 mmHg), per-protocol set, week 12 of 12 weeks, ANCOVA adjusted for baseline
“DBP (ls mean ± SE) was 77.4 ± 0.9 mmHg in the MKP group and 80.1 ± 0.9 mmHg in the placebo group at Week 12, which was significantly lower in the MKP group (ANCOVA; p < 0.05).”
- Interests
- Industry funded
- Population
- Healthy Japanese adults aged 20 to 74 with high-normal or elevated blood pressure (SBP 120-139 mmHg and/or DBP 80-89 mmHg), per-protocol set, week 12 of 12 weeks, ANCOVA adjusted for baseline
What did not
“There was no significant difference in the incidence of adverse events between the two groups (MKP group; 65.0%, placebo group; 59.3%, p > 0.1).”
- Interests
- Industry funded
- Population
- Healthy Japanese adults aged 20 to 74 with high-normal or elevated blood pressure, safety analysis set, 12 weeks
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Japanese adults aged 20 to 74 years with high-normal or elevated blood pressure (SBP above 120 or DBP above 80 mmHg, below 140/90), Matsumoto, Nagano; casein hydrolysate containing 100 ug casein-derived tripeptide Met-Lys-Pro (MKP) versus dextrin placebo, parallel groups
- Participants
- 121
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 7